BIOX fundamentals
An in-depth look to BIOCERES CROP SOLUTIONS CORP CEDEAR EACH 1 REPR 1 COM operating, investing, and financing activities
BIOX free cash flow for Q1 25 is -875.06 M ARS. For 2024, BIOX free cash flow was 4.44 B ARS and operating cash flow was 10.48 B ARS.
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: ARS
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM